Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audray K Harris

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Scientific Reports|July 10, 2018
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organizationDustin M McCraw, John R Gallagher, Udana Torian, et al.
Vaccines|May 26, 2018
Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron MicroscopyJohn R Gallagher, Dustin M McCraw, Udana Torian, et al.
Virus Research|March 26, 2025
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric statesMallory L Myers, Michael T Conlon, John R Gallagher, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric statesMallory L Myers, Michael T Conlon, John R Gallagher, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2013
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesAudray K Harris, Joel R Meyerson, Yumiko Matsuoka, et al.
Nature Communications|March 30, 2023
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodiesMallory L Myers, John R Gallagher, Alexander J Kim, et al.
Frontiers in Immunology|October 17, 2022
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Frontiers in Immunology|September 29, 2023
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protectionMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Plos Pathogens|August 28, 2023
Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopesDustin M McCraw, Mallory L Myers, Neetu M Gulati, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Scientific Reports|July 10, 2018
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organizationDustin M McCraw, John R Gallagher, Udana Torian, et al.
Vaccines|May 26, 2018
Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron MicroscopyJohn R Gallagher, Dustin M McCraw, Udana Torian, et al.
Virus Research|March 26, 2025
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric statesMallory L Myers, Michael T Conlon, John R Gallagher, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric statesMallory L Myers, Michael T Conlon, John R Gallagher, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2013
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesAudray K Harris, Joel R Meyerson, Yumiko Matsuoka, et al.
Nature Communications|March 30, 2023
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodiesMallory L Myers, John R Gallagher, Alexander J Kim, et al.
Frontiers in Immunology|October 17, 2022
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Frontiers in Immunology|September 29, 2023
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protectionMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Plos Pathogens|August 28, 2023
Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopesDustin M McCraw, Mallory L Myers, Neetu M Gulati, et al.
Pageof 3